Private, no accountPrivacy details: browsing privately, no account needed
You're browsing privately, no account needed. Your region stays in this session and your precise location is never stored.What we store
S. 164 · 117th CongressEnacted

Advancing Education on Biosimilars Act of 2021

Latest action. Became public lawWhat a bill becomes when enacted, numbered by Congress and order of enactment: Public Law 119-4 is the 4th law of the 119th Congress.Read the full definition (opens a new tab) No: 117-8. · April 23, 2021

Live record from Congress.gov, updated as the official record changes.
What this bill would do
Official summary · Congressional Research Service

Advancing Education on Biosimilars Act of 2021

This bill requires the Food and Drug Administration (FDA) to advance education and awareness among health care providers about biological products as appropriate, including by developing or improving continuing education programs that address the prescribing of biological products and biosimilars. (A biosimilar is a biological product that is highly similar to an FDA-approved reference biological product and has no clinically meaningful differences from that reference product.)

The FDA may also maintain and operate a website to provide educational materials about biological products.

Written by analysts at the Congressional Research Service and published on Congress.gov, not by Civibrief. Summarized at the "Public Law" stage on April 23, 2021. It describes the bill, it is not the legal text.

Status
Introduced
February 2, 2021
In committee
Passed a chamber
Cleared Congress
Enacted
April 23, 2021
Where this sits in the process
Common questions
Composed from the official record
Where is it in the process, and what happens next?

This bill has been enacted. It is law.

The record's latest action, on April 23, 2021: Became Public Law No: 117-8.

Has anyone actually voted on it?

No. No roll call in this Congress cites this measure. That is the ordinary outcome: most measures never reach a recorded floor vote, and a committee ends most of them simply by not acting.

A vote is not the only thing that happens to a measure. Hearings, markups, and referrals are all recorded actions, and none of them is a vote of the full chamber.

Who is behind it?

Maggie Hassan (D-NH) introduced it on February 2, 2021, and 1 member has since signed on as a cosponsor.

They are 1 Republican.

Cosponsoring is a formal signature on the text. It is not a commitment to vote for the measure, it does not bind anyone's party, and a long list of cosponsors is a measure of attention rather than of prospects.

Every answer above is assembled from this measure's own record on Congress.gov and from published counts of what Congress has passed before. Civibrief does not predict outcomes and takes no position on any measure.

Vote history

  1. Senate
    Passed
  2. House
    Passed
  3. President
    Signed into law
No recorded votes yet
No roll call in this Congress cites this bill. Most bills die in committee without ever reaching a recorded floor vote.